Zynerba Pharmaceuticals Inc
(NASDAQ : ZYNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.84%24.2714.1%$215.51m
SHPGShire PLC Sponsored ADR
-0.34%161.850.4%$146.66m
JAZZJazz Pharmaceuticals Plc
-0.91%178.502.2%$132.60m
SAGESAGE Therapeutics, Inc.
-4.83%153.469.6%$122.44m
ENDPEndo International Plc
1.94%9.488.9%$88.71m
PRGOPerrigo Co. Plc
0.40%75.656.7%$87.94m
ICPTIntercept Pharmaceuticals, Inc.
1.86%85.6721.8%$66.06m
MNKMallinckrodt Plc
-0.93%19.2621.1%$57.13m
PTLAPortola Pharmaceuticals, Inc.
4.14%43.737.7%$53.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.16%151.257.6%$52.62m
CTLTCatalent Inc
-0.67%41.542.6%$52.58m
SUPNSupernus Pharmaceuticals, Inc.
-2.23%57.056.3%$41.50m
HZNPHorizon Pharma plc
0.23%17.677.5%$38.10m
UTHRUnited Therapeutics Corporation
-0.22%116.4714.4%$36.89m
AERIAerie Pharmaceuticals, Inc.
4.60%70.457.9%$35.61m

Company Profile

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.